The 2020 Community Oncology Alliance (COA) Annual Conference had an educational agenda planned to benefit the nationwide workforce of community oncology professionals and allied industries. It was delivered through a cutting-edge webcast system with interactive features.
Journal of Clinical Pathways covered of the most relevant and important sessions of the meeting for our readership. Select session summaries are below. Full coverage accessible here.
Cancer Informatics in Telehealth, Clinical Decision Support
Debra Patt, MD, PhD, MBA, FASCO, executive vice president, policy and strategic initiatives, Texas Oncology, gave an overview of the “exciting new world” of applied informatics in oncology.
The Power and Potential of Genomic Profiling in Cancer Care
Lee Schwartzberg, MD, FACP, West Cancer Center and Research Institute, moderated a stakeholder panel discussion on utility and access issues of genomic profiling in cancer care.
Community Oncology Issues: Present and Future
A panel of community oncology leaders discussed the current challenges of delivering optimal care to their patients in light of the ongoing COVID-19 pandemic, as well as how future care is likely to be impacted by the demands of today.
Supporting Clinical Trials in the Community Oncology Setting
Howard “Skip” Burris, III, MD, FACP, FASCO, president and chief medical officer, Sarah Cannon Research Institute, and current American Society of Clinical Oncology president, discussed a successful clinical trial research program setup between Sarah Cannon Research Institute, Florida Cancer Specialists, and Tennessee Oncology.
